Add like
Add dislike
Add to saved papers

Assessment of knot security in continuous intradermal wound closures.

BACKGROUND: The traditionally used square knot used for commencement and termination of continuous wound closures is bulky, requiring a minimum of four to six throws to form a secure knot with most suture materials and sizes. This study evaluates the security of self-locking knots, which are significantly smaller in volume than the traditionally applied square knot, for the intradermal closure of standardized wounds in porcine skin.

MATERIALS: Porcine skin samples with standardized wounds were closed in one of five patterns with 3/0 PDS suture. Wounds were harvested and tested to failure on a materials testing machine. Load at failure, ultimate elongation, wound stiffness, and mode of failure was determined for each sample.

RESULTS: Wound closures incorporating the chain stitch knot performed as well as closures incorporating the conventional square knot for load to failure, elongation, and stiffness. Partial slippage or complete knot failure of 4/40 (10%) of the square knots used in closures was observed. 0/20 (0%) of the chain stitch knots displayed slippage. The half-blood knot performed similarly to the square and chain stitch knot in load to failure, elongation, and stiffness, however, 16/20 (80%) of these knots displayed slippage or complete knot failure.

CONCLUSIONS: The chain stitch knot is as secure as the traditionally used square knot when used for termination of a continuous intradermal wound closure. This knot displays characteristics such as smaller knot volume and ease of applications that may make it a superior knot to the square knot in many clinical situations.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app